ZIM LABORATORIES
|
ZIM LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹49 Cr | ₹49 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
Equity - Authorised | ₹75 Cr | ₹75 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
Equity - Issued | ₹49 Cr | ₹49 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
Equity Paid Up | ₹49 Cr | ₹49 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | ₹0.36 Cr |
Total Reserves | ₹190 Cr | ₹152 Cr | ₹159 Cr | ₹145 Cr | ₹137 Cr |
Securities Premium | ₹9.09 Cr | ₹9.09 Cr | ₹41 Cr | ₹41 Cr | ₹41 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹157 Cr | ₹141 Cr | ₹117 Cr | ₹102 Cr | ₹95 Cr |
General Reserves | - | - | ₹1.06 Cr | ₹1.06 Cr | ₹1.06 Cr |
Other Reserves | ₹23 Cr | ₹1.96 Cr | ₹0.82 Cr | ₹0.46 Cr | ₹0.52 Cr |
Reserve excluding Revaluation Reserve | ₹190 Cr | ₹152 Cr | ₹159 Cr | ₹145 Cr | ₹137 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹239 Cr | ₹200 Cr | ₹176 Cr | ₹161 Cr | ₹154 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹36 Cr | ₹25 Cr | ₹19 Cr | ₹22 Cr | ₹27 Cr |
Non Convertible Debentures | - | - | - | ₹19 Cr | ₹27 Cr |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹44 Cr | ₹26 Cr | ₹24 Cr | ₹17 Cr | ₹1.22 Cr |
Term Loans - Institutions | ₹6.86 Cr | ₹11 Cr | ₹10 Cr | - | ₹11 Cr |
Other Secured | ₹-16 Cr | ₹-12 Cr | ₹-15 Cr | ₹-15 Cr | ₹-13 Cr |
Unsecured Loans | - | - | - | - | ₹0.41 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | ₹0.41 Cr |
Deferred Tax Assets / Liabilities | ₹10 Cr | ₹4.80 Cr | ₹0.36 Cr | ₹-2.61 Cr | ₹-5.33 Cr |
Deferred Tax Assets | ₹1.08 Cr | ₹4.22 Cr | ₹9.15 Cr | ₹12 Cr | ₹15 Cr |
Deferred Tax Liability | ₹11 Cr | ₹9.03 Cr | ₹9.52 Cr | ₹8.92 Cr | ₹9.78 Cr |
Other Long Term Liabilities | ₹2.95 Cr | ₹1.02 Cr | ₹0.72 Cr | ₹0.17 Cr | ₹0.63 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | - | - | ₹0.01 Cr | - |
Total Non-Current Liabilities | ₹49 Cr | ₹30 Cr | ₹20 Cr | ₹19 Cr | ₹23 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹62 Cr | ₹58 Cr | ₹81 Cr | ₹65 Cr | ₹66 Cr |
Sundry Creditors | ₹62 Cr | ₹58 Cr | ₹81 Cr | ₹65 Cr | ₹66 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹41 Cr | ₹29 Cr | ₹45 Cr | ₹31 Cr | ₹27 Cr |
Bank Overdraft / Short term credit | - | - | - | ₹0.03 Cr | - |
Advances received from customers | ₹9.45 Cr | ₹4.41 Cr | ₹22 Cr | ₹8.23 Cr | ₹5.71 Cr |
Interest Accrued But Not Due | ₹0.14 Cr | ₹0.16 Cr | ₹0.12 Cr | ₹0.09 Cr | ₹0.10 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹32 Cr | ₹25 Cr | ₹23 Cr | ₹23 Cr | ₹21 Cr |
Short Term Borrowings | ₹55 Cr | ₹23 Cr | ₹17 Cr | ₹45 Cr | ₹50 Cr |
Secured ST Loans repayable on Demands | ₹55 Cr | ₹23 Cr | ₹17 Cr | ₹45 Cr | ₹50 Cr |
Working Capital Loans- Sec | ₹55 Cr | ₹23 Cr | ₹17 Cr | ₹45 Cr | ₹50 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-55 Cr | ₹-23 Cr | ₹-17 Cr | ₹-45 Cr | ₹-50 Cr |
Short Term Provisions | ₹0.80 Cr | ₹0.60 Cr | ₹4.24 Cr | ₹1.40 Cr | ₹1.06 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | ₹3.52 Cr | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.80 Cr | ₹0.60 Cr | ₹0.72 Cr | ₹1.40 Cr | ₹1.06 Cr |
Total Current Liabilities | ₹159 Cr | ₹111 Cr | ₹147 Cr | ₹142 Cr | ₹143 Cr |
Total Liabilities | ₹447 Cr | ₹342 Cr | ₹343 Cr | ₹322 Cr | ₹320 Cr |
ASSETS | |||||
Gross Block | ₹267 Cr | ₹199 Cr | ₹180 Cr | ₹165 Cr | ₹159 Cr |
Less: Accumulated Depreciation | ₹106 Cr | ₹90 Cr | ₹75 Cr | ₹59 Cr | ₹43 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹161 Cr | ₹109 Cr | ₹106 Cr | ₹107 Cr | ₹116 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹24 Cr | ₹18 Cr | ₹5.10 Cr | ₹4.56 Cr | ₹4.74 Cr |
Non Current Investments | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr |
Long Term Investment | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr |
Long Term Loans & Advances | ₹16 Cr | ₹14 Cr | ₹12 Cr | ₹11 Cr | ₹10 Cr |
Other Non Current Assets | ₹0.31 Cr | ₹0.52 Cr | ₹0.28 Cr | ₹1.85 Cr | ₹1.95 Cr |
Total Non-Current Assets | ₹219 Cr | ₹151 Cr | ₹129 Cr | ₹130 Cr | ₹138 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹81 Cr | ₹54 Cr | ₹75 Cr | ₹54 Cr | ₹56 Cr |
Raw Materials | ₹50 Cr | ₹36 Cr | ₹41 Cr | ₹31 Cr | ₹33 Cr |
Work-in Progress | ₹1.97 Cr | ₹5.89 Cr | ₹13 Cr | ₹11 Cr | ₹5.52 Cr |
Finished Goods | ₹25 Cr | ₹8.32 Cr | ₹17 Cr | ₹8.38 Cr | ₹12 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | ₹2.66 Cr | ₹2.62 Cr | ₹2.56 Cr | ₹2.08 Cr | ₹2.31 Cr |
Other Inventory | ₹1.85 Cr | ₹0.69 Cr | ₹1.42 Cr | ₹2.57 Cr | ₹2.57 Cr |
Sundry Debtors | ₹100 Cr | ₹95 Cr | ₹90 Cr | ₹72 Cr | ₹68 Cr |
Debtors more than Six months | ₹6.31 Cr | ₹8.84 Cr | ₹5.82 Cr | ₹13 Cr | ₹8.87 Cr |
Debtors Others | ₹95 Cr | ₹88 Cr | ₹85 Cr | ₹60 Cr | ₹68 Cr |
Cash and Bank | ₹10 Cr | ₹7.52 Cr | ₹4.97 Cr | ₹8.35 Cr | ₹3.95 Cr |
Cash in hand | ₹0.12 Cr | ₹0.08 Cr | ₹0.13 Cr | ₹0.06 Cr | ₹0.17 Cr |
Balances at Bank | ₹10 Cr | ₹7.44 Cr | ₹4.84 Cr | ₹8.29 Cr | ₹3.78 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹2.29 Cr | ₹2.57 Cr | ₹1.41 Cr | ₹1.55 Cr | ₹1.60 Cr |
Interest accrued on Investments | ₹0.00 Cr | ₹0.00 Cr | ₹0.01 Cr | ₹0.03 Cr | ₹0.08 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹0.03 Cr | ₹0.03 Cr | ₹0.03 Cr | ₹0.12 Cr | ₹0.06 Cr |
Prepaid Expenses | ₹1.83 Cr | ₹1.76 Cr | ₹0.98 Cr | ₹1.40 Cr | ₹1.47 Cr |
Other current_assets | ₹0.43 Cr | ₹0.78 Cr | ₹0.39 Cr | - | - |
Short Term Loans and Advances | ₹33 Cr | ₹32 Cr | ₹42 Cr | ₹55 Cr | ₹52 Cr |
Advances recoverable in cash or in kind | ₹5.24 Cr | ₹12 Cr | ₹16 Cr | ₹24 Cr | ₹25 Cr |
Advance income tax and TDS | - | - | ₹1.46 Cr | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹28 Cr | ₹20 Cr | ₹25 Cr | ₹31 Cr | ₹27 Cr |
Total Current Assets | ₹228 Cr | ₹191 Cr | ₹214 Cr | ₹192 Cr | ₹182 Cr |
Net Current Assets (Including Current Investments) | ₹68 Cr | ₹80 Cr | ₹66 Cr | ₹50 Cr | ₹39 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹447 Cr | ₹342 Cr | ₹343 Cr | ₹322 Cr | ₹320 Cr |
Contingent Liabilities | ₹5.85 Cr | ₹6.67 Cr | ₹6.98 Cr | ₹6.05 Cr | ₹5.89 Cr |
Total Debt | ₹106 Cr | ₹59 Cr | ₹51 Cr | ₹81 Cr | ₹90 Cr |
Book Value | - | 41.12 | 108.18 | 98.97 | 94.84 |
Adjusted Book Value | 49.00 | 41.12 | 36.06 | 32.99 | 31.61 |
Compare Balance Sheet of peers of ZIM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZIM LABORATORIES | ₹407.7 Cr | -3.5% | -21.4% | -17.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
ZIM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZIM LABORATORIES | -3.5% |
-21.4% |
-17.1% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses